(2023). Sodium channel-inhibiting drugs and cancer-specific survival: a population-based study of electronic primary care data. Bmj Open, 13, e064376. http://doi.org/10.1136/bmjopen-2022-064376.
(2023). Polypharmacy during pregnancy and associated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019. Bmc Med, 21, 21. http://doi.org/10.1186/s12916-022-02722-5.
(2022). Patterns of antiemetic medication use during pregnancy: A multi-country retrospective cohort study. Plos One, 17, e0277623. http://doi.org/10.1371/journal.pone.0277623.
(2022). The impact of repeated vaccination on relative influenza vaccine effectiveness among vaccinated adults in the United Kingdom. Epidemiol Infect, 150, e198. http://doi.org/10.1017/s0950268822001753.
(2022). Development of a treatment selection algorithm for SGLT2 and DPP-4 inhibitor therapies in people with type 2 diabetes: a retrospective cohort study. Lancet Digit Health, 4, e873-e883. http://doi.org/10.1016/s2589-7500(22)00174-1.
(2022). Development and external validation of a risk prediction model for falls in patients with an indication for antihypertensive treatment: retrospective cohort study. Bmj, 379, e070918. http://doi.org/10.1136/bmj-2022-070918.
(2022). Derivation and External Validation of a Clinical Model to Predict Heart Failure Onset in Patients With Incident Diabetes. Diabetes Care, 45, 2737-2745. http://doi.org/10.2337/dc22-0894.
(2022). Liver blood marker testing in UK primary care: a UK wide cohort study, 2004-2016. Bmj Open, 12, e058967. http://doi.org/10.1136/bmjopen-2021-058967.
(2022). Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting. Int J Chron Obstruct Pulmon Dis, 17, 2417-2429. http://doi.org/10.2147/copd.s370540.
(2022). Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β(2)-agonist dual therapy in a primary care setting in England. Bmj Open Respir Res, 9. http://doi.org/10.1136/bmjresp-2022-001243.